✨ Agricultural Compounds Notices
NEW ZEALAND GAZETTE, No. 69 — 4 AUGUST 2016
The following address is:
a. where submissions on this application are to be sent; and
b. where requests for copies of the public information relating to the application can be sent; and
c. where public information relating to the application can be viewed; and
d. the director-general’s address for service:
ACVM Group, Ministry for Primary Industries, Pastoral House, 25 The Terrace, Wellington 6011. Postal Address: PO Box 2526, Wellington 6140.
The applicant’s address for service is:
Zoetis New Zealand Limited, Level 5, 8 Mahuhu Crescent, Auckland Central, Auckland 1010. Postal Address: PO Box 2094, Shortland Street, Auckland 1140.
Dated at Wellington this 2nd day of August 2016.
MAREE ZINZLEY, Manager Approvals Operations, Ministry for Primary Industries (acting under delegated authority).
2016-go4495
Notice of Application to Vary the Conditions of a Registered Trade Name Product
(Notice No. MPI 667)
Maree Zinzley, Manager Approvals Operations of the Ministry for Primary Industries (MPI), acting under delegated authority from the Director-General of MPI, gives notice, under section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997 (“Act”), that the following variation application has been made to a registered trade name product under section 9(2) of the Act:
Trade Name: Bravecto Spot-On Solution
Reference: A011261
Active Ingredient and Concentration:
Fluralaner 280mg/mL
Formulation Type: Vapour releasing product
General Use Claim:
Control of tick and flea infestations on dogs.
- Immediate and persistent flea (Ctenocephalides sp.) killing activity for six months; and
- immediate and persistent tick (Haemaphysalis longicornis) killing activity for four months.
- Safe for use in breeding, pregnant and lactating dogs.
- Safe for use in MDR1 breeds.
- Controls immature stages of fleas and immature tick stages.
- Part of a treatment strategy for the control of flea allergy dermatitis.
- Highly effective against fipronil resistant fleas.
Proposed Variation to Conditions:
For the control of flea and tick infestations on dogs.
- Immediate and persistent flea (Ctenocephalides sp.) killing activity for six months; and
- immediate and persistent tick (Haemaphysalis longicornis) killing activity for four months.
- Treatment and control of Otodectes and Sarcoptes spp. mites.
- Safe for use in breeding, pregnant and lactating dogs.
- Safe for use in MDR1 breeds.
51
Next Page →
NZ Gazette 2016, No 69
✨ LLM interpretation of page content
🌾
Application to Register Trade Name Product CYTOPOINT
(continued from previous page)
🌾 Primary Industries & Resources2 August 2016
Agricultural Compounds, Veterinary Medicines, Dogs, Registration
- MAREE ZINZLEY, Manager Approvals Operations, Ministry for Primary Industries
🌾 Notice of Application to Vary the Conditions of a Registered Trade Name Product
🌾 Primary Industries & ResourcesAgricultural Compounds, Veterinary Medicines, Flea and Tick Control, Dogs, Variation Application
- Maree Zinzley, Manager Approvals Operations, Ministry for Primary Industries